# The Effect of Intravenous Dexmedetomidine During Surgery in the Prevention of Shivering After General Anesthesia in Patients Undergoing Spinal Surgery: A Randomized Clinical Trial

**Authors:** Mehdi Shokri, Zhale Bakhtiari, Bita Kargar, Amirhossein Hajialigol

PMC · DOI: 10.5812/aapm-159077 · 2025-05-18

## TL;DR

This study shows that using dexmedetomidine during spine surgery reduces postoperative shivering but can cause low blood pressure and slow heart rate.

## Contribution

The novel contribution is demonstrating the effectiveness of intraoperative dexmedetomidine in reducing postoperative shivering in prone-position spinal surgery patients.

## Key findings

- Dexmedetomidine significantly reduced shivering frequency and intensity after surgery.
- Dexmedetomidine was associated with higher rates of bradycardia and hypotension.
- Patients receiving dexmedetomidine had higher mean body temperatures post-surgery.

## Abstract

Postoperative shivering is an involuntary, spontaneous, and repetitive contraction of skeletal muscles that causes patient restlessness, increased oxygen consumption, wound infection, surgical bleeding, and cardiac events. Patients undergoing spine surgery in the prone position are particularly susceptible to hypothermia.

Given the importance of controlling postoperative shivering in these patients, the present study aimed to investigate the effect of intraoperative dexmedetomidine (Dex) infusion in preventing shivering after general anesthesia in patients undergoing spine surgery in the prone position.

In this double-blind randomized clinical trial, 60 American Society of Anesthesiologists (ASA) class I or II patients undergoing vertebral surgery in the prone position were enrolled. Patients in the study group (n = 30) received Dex infusion during surgery, while those in the placebo group (n = 30) received an equivalent volume of 0.9% normal saline. Hemodynamic variables, frequency and severity of shivering, and drug side effects were recorded.

The mean arterial pressure (MAP) at 90 minutes (P = 0.022), immediately before extubation (P = 0.001), and after extubation (P = 0.001), as well as HR values at 60 minutes (P = 0.020), 90 minutes (P = 0.001), immediately before extubation (P = 0.001), and after extubation (P = 0.001), were significantly lower in the study group compared to the placebo group. The frequency of bradycardia (26.7% vs. 0%, P = 0.002) and hypotension (20% vs. 0%, P = 0.012) was significantly higher in the study group. At all evaluated times, the mean body temperature in the study group was significantly higher than in the placebo group (P < 0.05). The frequency (10% vs. 30%, P = 0.003) and intensity (P = 0.001) of shivering in the study group were significantly lower than in the placebo group.

This study demonstrated that the preventive use of Dex infusion during surgery reduces the frequency and severity of postoperative shivering in patients undergoing spinal surgery in the prone position. However, this method was associated with hypotension and bradycardia in some patients.

## Linked entities

- **Chemicals:** dexmedetomidine (PubChem CID 5311068), doxorubicin (PubChem CID 31703)

## Full-text entities

- **Diseases:** bradycardia (MESH:D001919), hypothermia (MESH:D007035), bleeding (MESH:D006470), hypotension (MESH:D007022), infection (MESH:D007239), wound (MESH:D014947)
- **Chemicals:** oxygen (MESH:D010100), Dex (MESH:D020927)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12297032/full.md

---
Source: https://tomesphere.com/paper/PMC12297032